Salīdzināt metodes

	QSAR	Molekulārā dokēšana	Farmakofora modelēšana
Nozare	Bioinformātika	Bioinformātika	Bioinformātika
Saime	Process / pipeline	Process / pipeline	Process / pipeline
Izcelsmes gads	1964	1982	1977
Autors	Corwin Hansch	Irwin Kuntz	Peter Gund
Tips	Regression-based predictive modeling pipeline	Binding prediction pipeline	Pattern-based virtual screening pipeline
Pirmavots	Hansch, C. & Fujita, T. (1964). Rho-sigma-pi analysis. A method for the correlation of biological activity and chemical structure. Journal of the American Chemical Society, 86(8), 1616-1626.	Kuntz, I. D., Blaney, J. M., Oatley, S. J., Langridge, R., & Ferrin, T. E. (1982). A geometric approach to macromolecule-ligand interactions. Journal of Molecular Biology, 161(2), 269-288.	Wermuth, C. G., Ganellin, C. R., Lindberg, P., & Mitscher, L. A. (1998). Glossary of terms used in medicinal chemistry. Pure and Applied Chemistry, 70(5), 1129-1143.
Citi nosaukumi	QSAR model, quantitative structure-activity relationship	protein-ligand docking, binding prediction	pharmacophore pattern recognition, 3D pharmacophore
Saistītās	3	4	3
Kopsavilkums	Quantitative Structure-Activity Relationship (QSAR) modeling predicts biological activity from molecular structure using statistical or machine learning models. Pioneered by Hansch in 1964, QSAR correlates numerical molecular descriptors with measured bioactivity, enabling prediction of activity for untested compounds and rational lead optimization.	Molecular docking predicts the preferred binding orientation and affinity of a ligand (small molecule) within a protein binding pocket. Pioneered by Kuntz and colleagues in 1982, this computational method searches conformational space to find energetically favorable ligand-protein complexes, enabling rapid screening of chemical libraries for drug discovery.	Pharmacophore modeling identifies the spatial arrangement of molecular features (hydrogen bond donors, acceptors, aromatic rings) that are essential for biological activity. Introduced by Gund in 1977, this ligand-based method creates a three-dimensional pattern that can screen chemical libraries and design new active compounds without requiring receptor structure.